Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China flag China · Delayed Price · Currency is CNY
1.450
+0.080 (5.84%)
Jul 16, 2026, 3:00 PM CST

Kangmei Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
18,94626,41332,44125,78730,50142,839
Market Cap Growth
-28.45%-18.58%25.81%-15.46%-28.80%221.38%
Enterprise Value
17,92625,38931,91824,90428,79776,028
Last Close Price
1.371.912.341.862.203.09
PE Ratio
-2557.443783.85251.53-5.41
Forward PE
-2.562.562.562.562.56
PS Ratio
3.765.036.255.297.3010.32
PB Ratio
2.593.614.503.644.374.30
P/TBV Ratio
2.773.864.874.004.834.64
P/FCF Ratio
-----1006.12
P/OCF Ratio
119.93237.22---199.99
PEG Ratio
-0.530.530.530.530.53
EV/Sales Ratio
3.564.836.155.116.8918.31
EV/EBITDA Ratio
-493.17-52.89--
EV/EBIT Ratio
---138.67--
EV/FCF Ratio
-----1785.59
Debt / Equity Ratio
0.020.030.020.040.040.02
Debt / EBITDA Ratio
3.412.17-0.49--
Debt / FCF Ratio
-----4.82
Net Debt / Equity Ratio
-0.14-0.14-0.12-0.11-0.18-0.22
Net Debt / EBITDA Ratio
-59.84-20.516.64-1.701.700.89
Net Debt / FCF Ratio
15.639.991.711.921.56-51.99
Asset Turnover
0.370.390.370.330.270.17
Inventory Turnover
1.671.811.761.541.260.91
Quick Ratio
0.770.810.710.660.821.00
Current Ratio
1.261.261.171.121.361.68
Return on Equity (ROE)
-0.17%0.17%0.17%1.47%-31.78%-
Return on Assets (ROA)
-1.17%-1.03%-1.84%0.76%-4.17%-7.71%
Return on Invested Capital (ROIC)
3.07%-1.01%-2.28%2.80%-15.42%-33.25%
Return on Capital Employed (ROCE)
-3.20%-2.80%-5.20%2.20%-10.70%-27.40%
Earnings Yield
-0.08%0.04%0.03%0.40%-8.81%18.48%
FCF Yield
-0.36%-0.40%-1.51%-1.62%-2.62%0.10%
Payout Ratio
-----0.17%
Buyback Yield / Dilution
-15.27%-3.25%-39.38%27.54%-1.85%-0.55%
Total Shareholder Return
-15.27%-3.25%-39.38%27.54%-1.85%-0.55%